Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 2
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis.
Middha P, Thummalapalli R, Betti MJ, Yao L, Quandt Z, Balaratnam K, Bejan CA, Cardenas E, Falcon CJ, Faleck DM; Princess Margaret Lung Group; Gubens MA, Huntsman S, Johnson DB, Kachuri L, Khan K, Li M, Lovly CM, Murray MH, Patel D, Werking K, Xu Y, Zhan LJ, Balko JM, Liu G, Aldrich MC, Schoenfeld AJ, Ziv E. Middha P, et al. Among authors: balaratnam k. medRxiv [Preprint]. 2023 Sep 13:2023.05.15.23289680. doi: 10.1101/2023.05.15.23289680. medRxiv. 2023. PMID: 37292751 Free PMC article. Updated. Preprint.
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis.
Middha P, Thummalapalli R, Betti MJ, Yao L, Quandt Z, Balaratnam K, Bejan CA, Cardenas E, Falcon CJ, Faleck DM; Princess Margaret Lung Group; Gubens MA, Huntsman S, Johnson DB, Kachuri L, Khan K, Li M, Lovly CM, Murray MH, Patel D, Werking K, Xu Y, Zhan LJ, Balko JM, Liu G, Aldrich MC, Schoenfeld AJ, Ziv E. Middha P, et al. Among authors: balaratnam k. Nat Commun. 2024 Mar 26;15(1):2568. doi: 10.1038/s41467-023-44512-4. Nat Commun. 2024. PMID: 38531883 Free PMC article.
Real-World Treatment Sequencing, Toxicities, Health Utilities, and Survival Outcomes in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung Cancer.
Schmid S, Cheng S, Chotai S, Garcia M, Zhan L, Hueniken K, Balaratnam K, Khan K, Patel D, Grant B, Raptis R, Brown MC, Xu W, Moriarty P, Shepherd FA, Sacher AG, Leighl NB, Bradbury PA, Liu G. Schmid S, et al. Among authors: balaratnam k. Clin Lung Cancer. 2023 Jan;24(1):40-50. doi: 10.1016/j.cllc.2022.09.007. Epub 2022 Sep 24. Clin Lung Cancer. 2023. PMID: 36270866
Treatment patterns and outcomes in early-stage ALK-rearranged non-small cell lung cancer.
Schmid S, Garcia M, Cheng S, Zhan L, Chotai S, Balaratnam K, Khan K, Patel D, Catherine Brown M, Sachdeva R, Xu W, Shepherd FA, Sacher A, Leighl NB, Bradbury P, Moriarty P, Sara Kuruvilla M, Liu G. Schmid S, et al. Among authors: balaratnam k. Lung Cancer. 2022 Apr;166:58-62. doi: 10.1016/j.lungcan.2022.01.020. Epub 2022 Feb 3. Lung Cancer. 2022. PMID: 35183992
EGFR mutation prevalence, real-world treatment patterns, and outcomes among patients with resected, early-stage, non-small cell lung cancer in Canada.
Sara Kuruvilla M, Liu G, Syed I, Gwadry-Sridhar F, Sheffield BS, Sachdeva R, Pencz A, Zhan L, Hueniken K, Patel D, Balaratnam K, Khan K, Grant B, Noy S, Singh K, Liu L, Rakibuz-Zaman M, Moldaver D, Kate Shanahan M, Cheema PK. Sara Kuruvilla M, et al. Among authors: balaratnam k. Lung Cancer. 2022 Nov;173:58-66. doi: 10.1016/j.lungcan.2022.08.023. Epub 2022 Sep 12. Lung Cancer. 2022. PMID: 36152478
Systemic Inflammatory Markers of Survival in Epidermal Growth Factor-Mutated Non-Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysis.
Chan SWS, Smith E, Aggarwal R, Balaratnam K, Chen R, Hueniken K, Fazelzad R, Weiss J, Jiang S, Shepherd FA, Bradbury PA, Sacher AG, Leighl NB, Xu W, Brown MC, Eng L, Liu G. Chan SWS, et al. Among authors: balaratnam k. Clin Lung Cancer. 2021 Sep;22(5):390-407. doi: 10.1016/j.cllc.2021.01.002. Epub 2021 Jan 10. Clin Lung Cancer. 2021. PMID: 33582072
Presentation and outcomes of KRASG12C mutant non-small cell lung cancer patients with stage IV disease at diagnosis (de novo) versus at recurrence.
Esfahanian N, Chan SWS, Zhan LJ, Brown MC, Khan K, Lee J, Balaratnam K, Yan E, Parker J, Garcia-Pardo M, Barghout SH, Eng L, Bradbury PA, Shepherd FA, Leighl NB, Sacher AG, Snow S, Juergens R, Liu G. Esfahanian N, et al. Among authors: balaratnam k. Cancer Treat Res Commun. 2023;37:100774. doi: 10.1016/j.ctarc.2023.100774. Epub 2023 Nov 4. Cancer Treat Res Commun. 2023. PMID: 37979334 Free article.
Age differences in patterns and confidence of using internet and social media for cancer-care among cancer survivors.
Eng L, Bender J, Hueniken K, Kassirian S, Mitchell L, Aggarwal R, Paulo C, Smith EC, Geist I, Balaratnam K, Magony A, Liang M, Yang D, Jones JM, Brown MC, Xu W, Grover SC, Alibhai SMH, Liu G, Gupta AA. Eng L, et al. Among authors: balaratnam k. J Geriatr Oncol. 2020 Jul;11(6):1011-1019. doi: 10.1016/j.jgo.2020.02.011. Epub 2020 Mar 10. J Geriatr Oncol. 2020. PMID: 32169545
Health-related social media use and preferences of adolescent and young adult cancer patients for virtual programming.
Aggarwal R, Hueniken K, Eng L, Kassirian S, Geist I, Balaratnam K, Liang M, Paulo CB, Geist A, Rao P, Mitchell L, Magony A, Jones JM, Grover SC, Brown MC, Bender J, Xu W, Liu G, Gupta AA. Aggarwal R, et al. Among authors: balaratnam k. Support Care Cancer. 2020 Oct;28(10):4789-4801. doi: 10.1007/s00520-019-05265-3. Epub 2020 Jan 23. Support Care Cancer. 2020. PMID: 31974768